Success of Pulpectomy With Zinc Oxide-Eugenol Vs Calcium Hydroxide/Iodoform Paste in Primary Molars: A Clinical Study
Purpose: The purpose of this study was to compare clinical and radiographic success rates of zinc oxide-eugenol cement (ZOE) vs calcium hydroxide/iodoform paste (Vitapex) in pulpectomized primary molars at 6 and 12 months. Methods: Fifty-four mandibular primary molars from 42 children (average age 5.6±1.2 years) that met the inclusion criteria were allocated to either test material via block randomization. A 1-visit pulpectomy and stainless steel crown was performed by 1 investigator. The clinical and radiographic diagnoses were blindly assessed by another investigator with an intraexaminer reliability of 0.85 to 0.95 (kappa value). Results: At 6 and 12 months, the ZOE success rates were 48% and 85%, respectively, and the Vitapex success rates were 78% and 89%. The difference in success rates between materials at 6 months was statistically significant, but at 12 months it was not. Conclusions: Vitapex appeared to resolve furcation pathology at a faster rate than zinc oxide-eugenol at 6 months, while at 12 months, both materials yielded similar results.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Research Article
Publication date: July 1, 2008
More about this publication?
- Pediatric Dentistry is the official publication of the American Academy of Pediatric Dentistry, the American Board of Pediatric Dentistry and the College of Diplomates of the American Board of Pediatric Dentistry. It is published bi-monthly and is internationally recognized as the leading journal in the area of pediatric dentistry. The journal promotes the practice, education and research specifically related to the specialty of pediatric dentistry. This peer-reviewed journal features scientific articles, case reports and abstracts of current pediatric dental research.
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- Ingenta Connect is not responsible for the content or availability of external websites